Titre : | "Naloxone? Not for me!" First cross-assessment by patients and healthcare professionals of the risk of opioid overdose (2024) |
Auteurs : | A. AQUIZERATE ; M. ROUSSELET ; A. COCHARD ; M. GUERLAIS ; M. GÉRARDIN ; E. LEFEBVRE ; M. DUVAL ; E. J. LAFORGUE ; C. VICTORRI-VIGNEAU |
Type de document : | Article : Périodique |
Dans : | Harm Reduction Journal (Vol.21, 2024) |
Article en page(s) : | art. 20 |
Langues: | Anglais |
Discipline : | PRE (Prévention - RdRD / Prevention - Harm reduction) |
Mots-clés : |
Thésaurus géographique FRANCE ; PAYS DE LA LOIREThésaurus mots-clés ENQUETE ; NALOXONE ; SURDOSE ; OPIOIDES ; TRAITEMENT DE MAINTENANCE ; PHARMACIE ; USAGER ; FACTEUR DE RISQUE ; PHARMACIEN ; REDUCTION DES RISQUES ET DES DOMMAGES |
Résumé : |
BACKGROUND: Opioid-related mortality is a rising public health concern in France, where opioids were in 2021 implicated in 75% of overdose deaths. Opioid substitution treatment (OST) was implicated in almost half of deaths related to substance and drug abuse. Although naloxone could prevent 80% of these deaths, there are a number of barriers to the distribution of take-home naloxone (THN) among opioid users in France. This study is the first one which compares patients' self-assessment of the risk of future opioid overdose with the hetero-assessment provided by healthcare professionals in a population of individuals eligible for naloxone.
METHODS: This was a multicenter descriptive observational study carried out in pharmacies across the Pays de la Loire region (France) during April and May 2022. All adult patients who visited a participating pharmacy for a prescription of OST and provided oral informed consent were enrolled in the study. Retrospective data were collected through cross-sectional interviews conducted by the pharmacist with the patient, utilizing an ad hoc questionnaire. The patient's self-assessment of overdose risk was evaluated using a Likert scale from 0 to 10. The pharmacist relied on the presence or absence of overdose risk situations defined by the French Health Authority (HAS). The need to hold THN was assessed using a composite criterion. RESULTS: A total of 34 patients were interviewed; near one third were aware of the existence of THN and a minority had THN in their possession. Out of the 34 participants, 29 assessed their own risk of future opioid overdose: 65.5% reported having zero risk, while 6.9% believed they had a high risk. Nevertheless, at least one risk situation of opioid overdose was identified according to HAS criteria in 73.5% of the participants (n = 25). Consequently, 55% of the participants underestimated their risk of experiencing a future opioid overdose. Yet, dispensing THN has been judged necessary for 88.2% of the participants. CONCLUSION: This study underscored the imperative need to inform not only healthcare professionals but also the patients and users themselves on the availability of THN and the risk situations of opioid overdose. |
Domaine : | Autres substances / Other substances ; Drogues illicites / Illicit drugs |
Refs biblio. : | 50 |
Affiliation : |
Nantes Université, CHU Nantes, Centre d'Evaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, Nantes, France Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients-Centered Outcomes and HEalth Research, SPHERE, Nantes, France |
Lien : | https://doi.org/10.1186/s12954-024-00941-y |
Accueil